In last trading session, Kazia Therapeutics Limited ADR (NASDAQ:KZIA) saw 103.73 million shares changing hands with its beta currently measuring 2.10. Company’s recent per share price level of $1.90 trading at $0.52 or 37.68% at ring of the bell on the day assigns it a market valuation of $6.33M. That closing price of KZIA’s stock is at a discount of -731.58% from its 52-week high price of $15.80 and is indicating a premium of 30.53% from its 52-week low price of $1.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 64510.0 shares which gives us an average trading volume of 100.47K if we extend that period to 3-months.

For Kazia Therapeutics Limited ADR (KZIA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.

Kazia Therapeutics Limited ADR (NASDAQ:KZIA) trade information

Upright in the green during last session for gaining 37.68%, in the last five days KZIA remained trading in the green while hitting it’s week-highest on Thursday, 01/30/25 when the stock touched $1.90 price level, adding 28.03% to its value on the day. Kazia Therapeutics Limited ADR’s shares saw a change of 7.34% in year-to-date performance and have moved 29.25% in past 5-day. Kazia Therapeutics Limited ADR (NASDAQ:KZIA) showed a performance of -38.11% in past 30-days. Number of shares sold short was 18773.0 shares which calculate 0.11 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 11.47% during past 5 years.

Kazia Therapeutics Limited ADR (NASDAQ:KZIA)’s Major holders

Investors also watch the number of corporate investors in a company very closely, which is 7.06% institutions for Kazia Therapeutics Limited ADR that are currently holding shares of the company. MORGAN STANLEY is the top institutional holder at KZIA for having 0.2 million shares of worth $45967.0. And as of 2024-06-30, it was holding 0.8386 of the company’s outstanding shares.

The second largest institutional holder is BNP PARIBAS ARBITRAGE, SNC, which was holding about 63568.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.2651 of outstanding shares, having a total worth of $14532.0.